SCHEMBL11063618

SCHEMBL11063618

CCCCCCCCCCCCCCCCCC=CC(=O)OC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 5/20 0.51
▸ PPARA Q07869 5/20 0.51
▸ CNR1 P21554 1/20 0.51
▸ CNR2 P34972 1/20 0.51
▸ TERT O14746 3/20 0.50
▸ PTPN1 P18031 3/20 0.50
▸ PPARD Q03181 3/20 0.50
▸ CYP1A2 P05177 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ BLM P54132 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ FABP4 P15090 2/20 0.50
▸ FAAH O00519 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ GMNN O75496 1/20 0.50
▸ USP2 O75604 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL728273 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL3508416 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL9244975 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL2855264 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL14672867 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL11059752 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL6896336 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL22555434 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL22555479 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT
SCHEMBL14035480 1.00 PPARG (0.51) PPARGPPARACNR1CNR2TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4049994-A1 ESTER COMPOUND AND PREPARATION METHOD THEREFOR AND USES THEREOF China Petroleum & Chemical Corporation (CN) 2022-08-31 — — EP claimed
CN-116640618-B Peony peptide and peony seed oil peptide with immunity improving and brain strengthening effects, and preparation methods and applications thereof 广州迪卡德营养科技有限公司 2023-12-01 — — CN disclosed
CN-117054550-A Method for detecting 38 fatty acids in erythrocyte membrane 福建医科大学 2023-11-14 — — CN disclosed
CN-116640618-A Peony peptide and peony seed oil peptide with immunity improving and brain strengthening effects, and preparation methods and applications thereof 山东牡丹爱生物科技有限公司 2023-08-25 — — CN disclosed
US-20230012456-A1 ESTER COMPOUND AND PREPARATION METHOD THEREFOR AND USES THEREOF RESEARCH INSTITUTE OF PETROLEUM PROCESSING, SINOPEC (CN) 2023-01-12 — — US disclosed
CN-115304485-A Oil product antirust additive, preparation method thereof and oil product composition 中国石油化工股份有限公司 2022-11-08 — — CN disclosed
CN-112707834-B Ester compound and preparation method and application thereof 中国石油化工股份有限公司 2022-10-21 — — CN disclosed
EP-4049994-A1 ESTER COMPOUND AND PREPARATION METHOD THEREFOR AND USES THEREOF China Petroleum & Chemical Corporation (CN) 2022-08-31 — — EP disclosed
CN-105241968-B A kind of method of quick detection whole blood Erythrocyte Fatty Acids 西安金域医学检验所有限公司 2017-12-26 — — CN disclosed
CN-105241968-A Method of quickly detecting fatty acid in whole blood red cell GUANGZHOU KINGMED DIAGNOSTICS CENTRAL CO LTD 2016-01-13 — — CN disclosed
CN-105136954-A Method for fast detecting whole red blood cell eicosaenoic acid GUANGZHOU KINGMED DIAGNOSTICS CENTRAL CO LTD 2015-12-09 — — CN disclosed
US-4472432-A ANTIDIABETIC, ANTILIPEMIC AGENTS INABATA & CO., LTD. (JP) 1984-09-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230012456-A1 ESTER COMPOUND AND PREPARATION METHOD THEREFOR AND USES THEREOF ALOX12, FAR1, ALOX15 PPARG 732/4885PPARA 329/4885CNR1 3294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback